C Ryan Miller Selected Research

C Ryan Miller Research Topics

Disease

50	Neoplasms (Cancer) 11/2023 - 02/2002
22	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 02/2002
19	Glioma (Gliomas) 09/2023 - 02/2002
14	Brain Neoplasms (Brain Tumor) 01/2023 - 10/2002
11	Breast Neoplasms (Breast Cancer) 10/2018 - 01/2011
4	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 07/2011
4	Neoplasm Metastasis (Metastasis) 11/2022 - 07/2011
4	Carcinogenesis 01/2018 - 02/2014
4	Melanoma (Melanoma, Malignant) 10/2017 - 05/2013
3	Triple Negative Breast Neoplasms 10/2017 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2022 - 07/2011
2	Disease Progression 01/2017 - 05/2013
2	Nevus (Nevi) 05/2015 - 05/2013
2	Lung Neoplasms (Lung Cancer) 07/2013 - 01/2013
2	Gastroesophageal Reflux (GERD) 10/2012 - 02/2011
2	Eosinophilic Esophagitis 10/2012 - 02/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Ascites 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Neutropenia 01/2018
1	Hyperglycemia 01/2018
1	Medulloblastoma 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Fatigue 01/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 09/2017 - 02/2002
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
6	Messenger RNA (mRNA)IBA 06/2015 - 02/2002
5	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2011
4	ChromatinIBA 01/2023 - 01/2013
4	Phosphotransferases (Kinase)IBA 01/2022 - 10/2017
3	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 01/2016
3	Formaldehyde (Formol)FDA Link 01/2021 - 07/2014
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 05/2013
3	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2014
3	Phenobarbital (Luminal)FDA Link 01/2018 - 03/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2013
3	1-dodecylpyridoxal (PLD)IBA 10/2017 - 01/2013
3	EnzymesIBA 10/2012 - 02/2002
2	Genetic Markers (Genetic Marker)IBA 01/2023 - 01/2020
2	Histones (Histone)IBA 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2015
2	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 01/2018
2	ParaffinIBA 01/2021 - 05/2015
2	c-Mer Tyrosine KinaseIBA 10/2018 - 05/2013
2	Estrogen ReceptorsIBA 01/2018 - 03/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 03/2016
2	human ERBB2 proteinIBA 01/2018 - 10/2017
2	AmberIBA 01/2018 - 03/2016
2	liposomal doxorubicin (Doxil)FDA Link 10/2017 - 01/2013
2	Bevacizumab (Avastin)FDA Link 01/2017 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 02/2002
2	Small Interfering RNA (siRNA)IBA 05/2015 - 05/2013
2	LigandsIBA 12/2014 - 05/2013
2	Fluorouracil (Carac)FDA LinkGeneric 03/2005 - 02/2002
1	Chemotactic FactorsIBA 11/2023
1	Interleukin-1 (Interleukin 1)IBA 11/2023
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 11/2023
1	CytokinesIBA 11/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2023
1	Quinolinic AcidIBA 01/2023
1	kynureninaseIBA 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	Long Noncoding RNAIBA 11/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	activin AIBA 01/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 10/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Amino Acids FDA Link 11/2019
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2019
1	alpha-hydroxyglutarateIBA 11/2019
1	UNC2025IBA 10/2018
1	thiamine triphosphorate (TTP)IBA 10/2018
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 10/2018
1	Everolimus FDA Link 10/2018
1	Trastuzumab (Herceptin)FDA Link 10/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2018
1	Glial Fibrillary Acidic ProteinIBA 10/2018
1	Vorinostat FDA Link 01/2018
1	PolymersIBA 01/2018
1	Platelet-Derived Growth FactorIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	navoximodIBA 01/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	Keratins (Keratin)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2017
1	NVP-BKM120IBA 10/2017
1	AZD 6244IBA 10/2017

Therapy/Procedure

27	Therapeutics 03/2024 - 03/2005
7	Drug Therapy (Chemotherapy) 01/2018 - 02/2002
4	Radiotherapy 01/2022 - 10/2002
1	Ketogenic Diet 11/2022
1	Isogeneic Transplantation 11/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020